This study aims to review novel materials for solid oxide fuel cell (SOFC) applications covered in literature. Thence, it was found that current SOFC operating conditions lead to issues, such as carbon surface deposition, sulfur poisoning and quick component degradation at high temperatures, which make it unsuitable for a few applications. Therefore, many researches are focused on cell performance enhancement through replacing the materials being used in order to improve properties and/or reduce operating temperatures. Most modifications in the anode aim to avoid some issues concerning conventionally used Ni-based materials, such as carbon deposition and sulfur poisoning, besides enhancing catalytic activity, once this component is directly exposed to the fuel. It was also found literature about the cathode with the aim of developing a material with enhanced properties in a wider temperature range, which has been compared to the currently used one: LSM perovskite (La 1-x Sr x MnO 3). Novel electrolyte materials can have ionic or protonic conductivity, thus performance degradation must be avoided at several operating conditions. In order to enhance its electrochemical performance, different materials for electrodes (cathode and anode) and electrolytes have been assessed herein.

-In general, lodging has been controlled by restricting nitrogen fertilizer application and/or using short cultivars. Growth retardants can also be used to solve this problem.The objective of this study was to evaluate the effect of rates and application times of three growth retardants on Pioneiro wheat cultivar. The trial was carried out in Viçosa-MG, from May to September 2005, in a factorial and hierarchical scheme, in a randomized block design with four replications and a control treatment. The treatments consisted of 500, 1,000 and 1,500 g ha -1 of chlormequat; 62.5, 125 and 187.5 g ha -1 of trinexapacethyl and 40, 80 and 120 g ha -1 of paclobutrazol applied at growth stages 6 or 8, growth stage used on the scale of Feeks and Large, and a control treatment without growth retardant application. Only trinexapac-ethyl and chlormequat were efficient in reducing plant height; the effect of chlormequat and paclobutrazol on plant height was independent of the application time, but the trinexapac-ethyl at growth stage 8 produced shorter plant height than at stage 6. Increasing growth retardant rates produced shorter plant heights; chlormequat and paclobutrazol did not affect grain yield. However, the highest trinexapac-ethyl rates reduced wheat yield.

No abstract

Introduction Tendinitis affects a substantial number of people in several occupations involving repetitive work or direct trauma. Iontophoresis is a therapeutic alternative used in the treatment of injury during the inflammatory phase. In recent years, gold nanoparticles (GNP) have been studied due to their therapeutic anti-inflammatory capacity and as an alternative to the transport of several proteins. Purpose This study evaluates the therapeutic effects of iontophoresis using GNPs and diclofenac diethylammonium on inflammatory parameters in rats challenged with traumatic tendinitis. Methods Wistar rats were divided in three treatment groups (n = 15): (1) iontophoresis + diclofenac diethylammonium; (2) iontophoresis + GNP; and (3) iontophoresis + diclofenac diethylammonium + GNP. External control was formed by challenged tendons without treatment (n = 15). Iontophoresis was administered using 0.3 mA direct current on 1.5 cm 2 electrodes. Results The levels of both inflammatory cytokines were significantly higher in untreated challenged rats, when compared with the control (5.398 ± 234 for interleukin 1 beta and 6.411 ± 432 for tumor necrosis factor alpha), which confirms the occurrence of an inflammatory stage in injury ( P < 0.05). A significant decrease was observed in expression of cytokines interleukin 1 beta in the three treatment groups, in comparison with untreated challenged tendons, although, in the group treated with diclofenac and GNP, results were similar to the control (1.732 ± 239) ( P < 0.05). Concerning tumor necrosis factor alpha, only the group treated with the association diclofenac and GNPs presented decreased levels, compared with the control (3.221 ± 369) ( P < 0.05). Conclusion The results show the efficacy of drug administration using direct current to treat tendinitis in an animal model, and the potential anti-inflammatory, carrier, and enhancing effects of GNPs in iontophoresis.

BackgroundThe purpose of this study was to evaluate the antimicrobial activity of two nitric oxide donors, ie, S-nitrosoglutathione (GSNO) and S-nitroso-N-acetylcysteine (SNAC), against clinical isolates from patients with infectious keratitis.MethodsReference broth microdilution assays were performed to determine the minimum inhibitory and bactericidal concentrations for GSNO and SNAC against four American Type Culture Collection strains and 52 clinical isolates from patients with infectious keratitis as follows: 14 (26.9%) Pseudomonas species; 13 (25.0%) coagulase-negative Staphylococci; 10 (19.2%) Staphylococcus aureus; nine (17.3%) Serratia marcescens; and six (11.5%) Enterobacter aerogenes. Sterility control and bacterial growth control were also performed.ResultsSNAC showed lower minimum inhibitory and bactericidal concentrations than GSNO for all clinical isolates from patients with infectious keratitis. For Gram-positive bacteria, mean minimum inhibitory and bactericidal concentrations were 2.1 ± 1.3 and 8.6 ± 3.8 mM for SNAC and 4.6 ± 3.2 and 21.5 ± 12.5 mM for GSNO (P < 0.01). For Gram-negative bacteria, mean minimum inhibitory and bactericidal concentrations were 3.3 ± 1.4 and 6.1 ± 3.4 mM for SNAC and 12.4 ± 5.4 and 26.5 ± 10.1 mM for GSNO (P < 0.01). The minimum bactericidal to inhibitory concentration ratio was ≤8 in 100% of all isolates tested for SNAC and in 94.2% tested for GSNO.ConclusionsSNAC and GSNO had effective inhibitory and bactericidal effects against bacterial isolates from keratitis. SNAC showed greater antimicrobial activity than GSNO against all bacteria. Gram-positive bacteria were more susceptible to the inhibitory and bactericidal effects of the S-nitrosothiols.

Mastitis is the most costly disease for dairy farmers and industry, which are mainly caused by the entry of bacteria to the teat canal. Shortly after the entry of the invading bacteria, the innate immunity recognizes the invading pathogen through pattern recognition receptors and initiates the inflammatory response necessary to eliminate the invading bacteria. This initial inflammatory response releases cytokines and chemoattractants for the rapid and massive influx of neutrophils from the blood to the site of infection which form the first line of cellular defense against bacteria This article reviewed the role of the most recent knowledge regarding the innate immunity in bovine mastitis focusing in the two major mastitis pathogens: Escherichia coli and Staphylococcus aureus the S. aureus appears to mostly circumvent the host immune response, as the Toll-Like Receptors (TLRs) signaling pathways. The Intramammary Infections (IMIs) by this bacteria result in a very moderate host response with minimal observable innate immune response, which are related to well-known ability to this pathogen to establish chronic IMI. Otherwise, E. coli elicits a strong and earlier response, mainly through TLR4, that is associated with the severity of the mastitis and the clinical manifestation commonly observed in dairy cows infected with this pathogen. Suboptimal and dysfunctional mammary defenses may contribute to the development of severe acute inflammation or chronic mastitis that adversely affects the milk production and quality. Thus, a better understanding of mastitis pathogen interaction to the host may be useful for future control of mastitis.

No abstract

ABSTRACT. We examined the frequency of RsaI polymorphism of the ERβ gene in 54 patients diagnosed with endometriosis and 46 controls. Peripheral blood was collected from women undergoing laparoscopy with a confirmed diagnosis of endometriosis. Polymorphisms of the ERβ gene and p53 were assessed by PCR and analyzed on 2% agarose gel stained with ethidium bromide. The AG polymorphism genotype frequency in patients with endometriosis was 59.3%, with 40.7% GG. In the control group, the frequency of AG was 6.5%, with 93.5% GG. The frequency of heterozygous AG was nine times higher in patients with endometriosis than in the control group (P < 0.0001).